Full-Time

Executive Director

Maintenance Operations

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

10,001+ employees

Teaching hospital delivering patient-centered medical care

Compensation Overview

$150k - $225k/yr

United States

Remote

Regular travel between facilities across the hospital system is required.

Bachelor's

Category
Facilities Operations (1)
Required Skills
HVAC
OSHA
Plumbing
Data Analysis

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Requirements
  • A bachelor's degree in Engineering, Facilities Management, or a related field; relevant experience may substitute for the educational requirement.
  • A minimum of 10 years of progressive leadership experience in healthcare facilities management or maintenance operations.
  • Experience managing large teams, complex infrastructure, and multimillion-dollar budgets.
  • Strong knowledge of building systems, life safety codes, and hospital maintenance best practices.
  • Ability to lead cross-functional teams in a complex, matrixed healthcare environment.
  • Proficiency in computerized maintenance management systems, project management tools, and data-driven decision-making.
  • Demonstrated financial management skills with experience overseeing capital and operating budgets.
  • Ability to analyze operational and financial data and translate insights into strategic decisions.
  • Ability to travel regularly between facilities across the hospital system.
  • Staff must be vaccinated against influenza as a condition of employment.
Responsibilities
  • Develop and implement a system-wide maintenance strategy aligned with organizational goals.
  • Identify and assist in managing capital and operational budgets for maintenance operations across all hospitals.
  • Establish performance benchmarks, key performance indicators, and reporting metrics to monitor and optimize maintenance outcomes.
  • Collaborate with executive leadership on long-term facility planning, sustainability, and infrastructure modernization.
  • Develop and implement an asset management strategy.
  • Identify continuous improvement initiatives.
  • Evaluate and standardize workforce planning.
  • Establish and monitor system-wide maintenance performance standards, productivity metrics, and service level expectations.
  • Ensure consistency in maintenance operations, staffing models, and service delivery practices across facilities.
  • Monitor maintenance operations for assigned hospitals, ensuring 24/7 readiness of critical systems including heating, ventilation, and air conditioning, electrical, plumbing, life safety, and medical gas systems.
  • Lead standardization of maintenance procedures, preventive maintenance programs, and work order systems across the system.
  • Partner with the Director of Vendor Services to manage vendors, contract negotiations, and procurement related to maintenance services and equipment.
  • Lead emergency preparedness efforts related to infrastructure failure, disaster recovery, and utility interruption.
  • Lead implementation and adoption of system-wide maintenance standards and initiatives.
  • Monitor and audit facility conditions to ensure patient, staff, and visitor safety.
  • Work with hospital engineering and environmental services teams to support accreditation and inspection readiness.
  • Ensure ongoing survey readiness and compliance with applicable regulatory and accreditation requirements, including The Joint Commission, the Centers for Medicare & Medicaid Services, the Occupational Safety and Health Administration, the National Fire Protection Association, the Environmental Protection Agency, and state and local regulations.
  • Lead corrective action planning and compliance remediation resulting from regulatory inspections and audits.
  • Lead, mentor, and develop a team including directors, facility managers, engineers, and skilled trades staff.
  • Implement training programs and succession planning to ensure skilled workforce continuity.
  • Lead organizational change management associated with enterprise maintenance programs, standards, and technologies.
  • Provide leadership and direction to site-based directors and managers while promoting consistency in operational performance across the system.
  • Develop leadership talent and succession plans to build organizational capability and workforce sustainability.
Desired Qualifications
  • Certified Healthcare Facility Manager certification.
  • Experience overseeing multi-site or system-level operations in a hospital or large healthcare setting.
  • Exceptional leadership, organizational, and communication skills.
Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

View

Beth Israel Deaconess Medical Center (BIDMC) serves as a teaching hospital in Boston affiliated with Harvard Medical School, offering a wide range of medical services across inpatient, emergency, outpatient, and urgent care. Its care model centers on delivering high-quality medical treatment to patients, supported by patient access initiatives like OpenNotes, which lets patients view clinicians’ notes online to improve understanding and engagement in their care. The hospital also supports education and research through its affiliation with Harvard, attracting funding for studies and training programs. BIDMC differentiates itself through its patient-centered approach, active patient engagement tools, and a broad network of urgent care centers and outpatient services that extend access to healthcare. The goal is to provide comprehensive, accessible, evidence-based medical care while advancing medical education and research.

Company Size

10,001+

Company Stage

Grant

Total Funding

$5.4M

Headquarters

Boston, Massachusetts

Founded

1996

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BIDMC won a $1.63 million NIH R01 on June 25, 2026 for ADAMTS13 research.
  • Needham patient volume doubled over ten years, supporting a new ambulatory building.
  • BIDMC expanded NeuroXT's Alzheimer's collaboration on May 26, 2026, strengthening AI-clinical research ties.

What critics are saying

  • Vita v. BIDMC, filed February 2023, alleges website data sharing with Meta and Google.
  • Unionized residents ratified a first contract July 1, 2026, raising labor costs through 2029.
  • Needham expansion and 2031 cancer-hospital construction demand capital while reimbursement stays unforgiving.

What makes Beth Israel Deaconess Medical Center unique

  • Harvard-affiliated BIDMC drives translational research, training, and specialty care from Boston.
  • OpenNotes made BIDMC a national transparency pioneer, opening all clinicians' notes.
  • Dana-Farber collaboration anchors BIDMC in the region's only dedicated adult inpatient cancer hospital.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Boston Cambridge Biotech Networks
Sep 1st, 2026
Beth Israel Deaconess plans new building in Needham as patient volume doubles

Beth Israel Deaconess plans new building in Needham as patient volume doubles

Harvard Medical Faculty Physicians
Aug 6th, 2026
BIDMC nationally recognized by U.S. News & World Report

BIDMC nationally recognized by U.S. News & world report. BIDMC has once again been recognized as a leading hospital in Boston and the nation. The hospital was nationally ranked in eight adult specialties - OBGYN (#4), diabetes and endocrinology - BIDMC and the Joslin Diabetes Center (#9), gastroenterology and GI surgery (#26), cancer care (#28), pulmonary and lung surgery (#26), geriatrics (#36 - tied), cardiology, heart, and vascular surgery (#35-tied), and neurology and neurosurgery (#31). A special congratulations to the Department of Obstetrics and Gynecology, which achieved its highest-ever placement in the US News rankings, earning the No. 4 spot nationally and securing its first top five ranking. Congratulations to all HMFP physicians and staff whose clinical excellence, dedication, and commitment to our patients, communities, and one another are reflected in these prestigious honors. Click here for full coverage.

Harvard Medical Faculty Physicians
Aug 6th, 2026
BIDMC OB/GYN Program Ranked #4 in the Nation by U.S. News & World Report

BIDMC OB/GYN program ranked #4 in the nation by U.S. News & World Report. Beth Israel Deaconess Medical Center's (BIDMC) Department of Obstetrics and Gynecology has been ranked #4 in the nation for Obstetrics & Gynecology care in U.S. News & World Report's 2026-2027 Best Hospitals rankings. The department was also recognized as Nationally High Performing in Gynecologic Cancer Surgery. "This recognition belongs to our entire department. Every day, our team brings our core values of humanity, excellence, and equity to life through the care we provide," said Blair Wylie, MD, MPH, Chair of the Department of Obstetrics and Gynecology at BIDMC. "From routine care to the most complex needs, our patients trust us to be with them at every stage of their journey. It is a privilege to care for them, and they are the reason this work and this recognition are so meaningful." The U.S. News & World Report recognition is part of a broader showing for BIDMC in this year's rankings. The hospital placed among the top 50 hospitals nationwide in eight specialties, and was named the #3 best hospital in the Boston region and #3 best hospital in Massachusetts. Across its specialties and procedures and conditions, BIDMC received 20 high-performing ratings in total. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions for this year's rankings; fewer than half earned recognition in any of the 37 areas of care assessed. To determine the Best Hospitals rankings, U.S. News analyzed each hospital's performance using objective measures such as risk-adjusted mortality rates, preventable complications, and patient experience, drawing on data from more than 800 million patient care records. More information on the U.S. News & World Report Best Hospitals rankings, including the full specialty rankings and procedures and conditions methodologies, is available at health.usnews.com/best-hospitals.

Beth Israel Deaconess Medical Center
Aug 5th, 2026
Beth Israel Deaconess Medical Center nationally recognized by U.S. News & World Report.

Beth Israel Deaconess Medical Center nationally recognized by U.S. News & World Report. August 05, 2026 BIDMC named in top three hospitals in Massachusetts. Boston, MA - Beth Israel Deaconess Medical Center (BIDMC) has been recognized for its high-quality care by U.S. News & World Report's 2026-2027 Best Hospitals edition, placing in the top 50 hospitals nationwide in eight specialties. BIDMC was ranked in the top 10 nationwide for two of those specialties: obstetrics & gynecology and diabetes & endocrinology. BIDMC was also named as the #3 best hospital in the Boston Metro Area region and #3 best hospital in Massachusetts. "Being again nationally recognized by U.S. News & World Report reflects the high-quality care teams across BIDMC provide to patients and their families," said Pete Healy, president, BIDMC & divisional president, Metro Boston, Beth Israel Lahey Health. "I am thankful for the commitment of our physicians, nurses, and staff to excellent and compassionate care." The eight specialties that BIDMC received national rankings include: * Obstetrics & Gynecology * Diabetes & Endocrinology * Gastroenterology & GI surgery * Pulmonology & Lung surgery * Cancer Care * Neurology & Neurosurgery * Heart & Vascular * Geriatrics The hospital received 20 high-performing ratings across specialties and procedures & conditions, including aortic valve surgery; colon cancer surgery; ear, nose & throat surgery; gynecological cancer surgery; heart bypass surgery; heart failure; kidney failure; leukemia, lymphoma & myeloma; lung cancer surgery; prostate cancer surgery; stroke; and urology. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions; less than half earned recognition in any of those 37 areas of care. To determine the Best Hospitals, U.S. News analyzed each hospital's performance based on objective measures such as risk-adjusted mortality rates, preventable complications and patient experience. The Best Hospitals Specialty rankings methodology and Procedures & Conditions ratings methodology measure patient outcomes using data from over 800 million records of patient care. About Beth Israel Deaconess Medical Center. Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox. Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a healthcare system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education. Director of Media Relations Sarah finlaw. Please note: The contact information above is for journalists and news media only. For patient care and all other inquiries, please contact your doctor or BIDMC directly.

Harvard Health Publishing
Jul 20th, 2026
Newly approved pill cuts LDL cholesterol levels by more than half.

Newly approved pill cuts LDL cholesterol levels by more than half. News briefs. July 20, 2026 * Reviewed by Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing A new pill that dramatically lowers harmful LDL cholesterol may be a good option for people who can't tolerate statins or who haven't lowered their LDL enough despite their current treatment with cholesterol-lowering drugs. Approved by the FDA in July 2026, enlicitide (Lipfendra) is the first oral version of a class of drugs known as PCSK9 inhibitors. These drugs work by mimicking the effect of a naturally occurring variant in the PCSK9 gene that leads to very low LDL levels. But the original drugs - which are given by injection once or twice a month - aren't widely used. Some people aren't comfortable giving themselves an injection. Also, most insurance companies won't cover the cost (which range from $200 to $500 or more per month) until a person has tried other therapies without success. Enlicitide is a daily pill that must be taken on an empty stomach with a sip of water, black coffee, or plain tea. It lowers LDL by nearly 60%, which is similar to the injectable PCSK9 drugs. Less than 10% of users experienced either dizziness or diarrhea, the two most common side effects. A month's supply will cost about $300; for now, insurance coverage remains unclear. You might also be interested in... Managing Your Cholesterol. Managing Your Cholesterol offers up-to-date information to help you or a loved one keep cholesterol in check. The report spells out what are healthy and unhealthy cholesterol levels, and offers specific ways to keep cholesterol in line. It covers cholesterol tests and the genetics of cholesterol. The report also focuses on treatments based on the latest scientific evidence, including the pros and cons of statins and other medications, and provides the lowdown on other substances advertised to lower cholesterol. Managing Your Cholesterol can also help you work with your doctor to individualize your treatment. The drug might be especially helpful for people whose LDL remains above recommended levels, despite taking cholesterol-lowering drug such as statins. The 2026 cholesterol guidelines recommend that people who've had a heart attack or stroke should aim for an LDL cholesterol of less than 55 milligrams per deciliter. The injectable PCSK9 drugs, alirocumab (Praluent) and evolocumab (Repatha), have been shown to reduce the incidence of heart attacks, strokes, and death from cardiovascular disease by up to 20% among people at high risk, over periods of up to at least five years. A similar study is currently underway to see if enlicitide offers the same benefit, with results expected in several years. Julie Corliss has been the executive editor of the Harvard Heart Letter since 2013. She also writes for the Harvard Health Letter, Harvard Women's Health Watch, and Harvard Men's Health Watch, as well as for Harvard... See Full Bio About the reviewer. Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing Dr. Robert H. Shmerling is the former clinical chief of the division of rheumatology at Beth Israel Deaconess Medical Center (BIDMC), and is a current member of the corresponding faculty in medicine at Harvard Medical School... See Full Bio Disclaimer: As a service to its readers, Harvard Health Publishing provides access to its library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.